Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies

Digitalomics - digital transformation leading to omics insights

INTRODUCTION

Biomarker discovery is increasingly moving from single omics to multiomics, as well as from multi-cell omics to single-cell omics. These transitions have increasingly adopted digital transformation technologies to accelerate the progression from data to insight. Here, we will discuss the concept of 'digitalomics' and how digital transformation directly impacts biomarker discovery. This will ultimately assist clinicians in personalized therapy and precision-medicine treatment decisions.

AREAS COVERED

Genotype-to-phenotype-based insight generation involves integrating large amounts of complex multiomic data. This data integration and analysis is aided through digital transformation, leading to better clinical outcomes. We also highlight the challenges and opportunities of Digitalomics, and provide examples of the application of Artificial Intelligence, cloud- and high-performance computing, and use of tensors for multiomic analysis workflows.

EXPERT OPINION

Biomarker discovery, aided by digital transformation, is having a significant impact on cancer, cardiovascular, infectious, immunological, and neurological diseases, among others. Data insights garnered from multiomic analyses, combined with patient meta data, aids patient stratification and targeted treatment across a broad spectrum of diseases. Digital transformation offers time and cost savings while leading to improved patent healthcare. Here, we highlight the impact of digital transformation on multiomics- based biomarker discovery with specific applications related to oncology.

Revolutionizing Healthcare: The Emerging Role of Quantum Computing in Enhancing Medical Technology and Treatment

The healthcare sector faces complex challenges that call for innovative solutions to improve diagnostic accuracy, treatment efficacy, and data management. Quantum computing, with its unique capabilities, holds the potential to revolutionize various aspects of healthcare. This narrative review critically examines the existing literature on the application of quantum computing in healthcare, focusing on its utility in enhancing diagnostics, data processing, and treatment planning. Quantum computing's ability to handle large, complex datasets more efficiently than classical computers can significantly impact domains such as genomics, medical imaging, and personalized medicine. Quantum algorithms can accelerate the identification of genetic markers associated with diseases, facilitate the analysis of medical images, and optimize treatment plans based on individual genetic profiles. Moreover, quantum cryptography offers a robust security solution for safeguarding sensitive patient data, a critical need as healthcare increasingly relies on digital platforms. Despite the promising outlook, the integration of quantum computing into healthcare faces technical, ethical, and regulatory challenges. The delicate nature of quantum hardware, the need for error correction, and the scalability of quantum systems pose barriers to widespread adoption. Additionally, concerns around patient privacy and data security, as well as the need for updated regulatory frameworks, must be addressed. Ongoing research and collaborative efforts involving researchers, healthcare providers, and technology developers are crucial to overcoming these hurdles and realizing the full potential of quantum computing in transforming healthcare. As quantum computing continues to evolve, its impact on the future of healthcare could be profound, leading to earlier disease detection, more personalized treatments, and improved patient outcomes. For instance, quantum computing has already been applied to enhance drug discovery processes, with companies like D-Wave Systems (Burnaby, Canada) demonstrating faster molecular simulations for pharmaceutical research and IBM's (Armonk, USA) quantum systems being used to model chemical reactions for new drug development.

A Novel Framework for Data Assessment That Uses Edge Technology to Improve the Detection of Communicable Diseases

Spreading quickly throughout populations, whether animal or human-borne, infectious illnesses provide serious risks and difficulties. Controlling their spread and averting disinformation requires effective risk assessment and epidemic identification. Technology-enabled data analysis on diseases allows for quick solutions to these problems. A Combinational Data Assessment Scheme intended to accelerate disease detection is presented in this paper. The suggested strategy avoids duplicate data replication by sharing data among edge devices. It uses indexed data gathering to improve early detection by using tree classifiers to discern between various kinds of information. Both data similarity and index measurements are considered throughout the data analysis stage to minimize assessment errors. Accurate risk detection and assessment based on information kind and sharing frequency are ensured by comparing non-linear accumulations with accurate shared edge data. The suggested system exhibits high accuracy, low mistakes, and decreased data repetition to improve overall effectiveness in illness detection and risk reduction.

Confronting the Disruption of the Infectious Diseases Workforce by Artificial Intelligence: What This Means for Us and What We Can Do About It

With the rapid advancement of artificial intelligence (AI), the field of infectious diseases (ID) faces both innovation and disruption. AI and its subfields including machine learning, deep learning, and large language models can support ID clinicians' decision making and streamline their workflow. AI models may help ensure earlier detection of disease, more personalized empiric treatment recommendations, and allocation of human resources to support higher-yield antimicrobial stewardship and infection prevention strategies. AI is unlikely to replace the role of ID experts, but could instead augment it. However, its limitations will need to be carefully addressed and mitigated to ensure safe and effective implementation. ID experts can be engaged in AI implementation by participating in training and education, identifying use cases for AI to help improve patient care, designing, validating and evaluating algorithms, and continuing to advocate for their vital role in patient care.